These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6277133)

  • 21. Prostaglandin and cyclic AMP regulation of macrophage involvement in connective tissue destruction.
    Wahl LM; Olsen CE; Wahl SM; McCarthy JB; Sandberg AL; Mergenhagen SE
    Ann N Y Acad Sci; 1979; 332():271-8. PubMed ID: 93863
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of alpha-tocopherol on platelet membrane function in cystic fibrosis.
    Davis PB; Hubbard VS; Dieckman L; Boat TF; Stern RC; Doershuk CF
    J Lab Clin Med; 1984 Aug; 104(2):203-12. PubMed ID: 6086795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of antibodies on platelets.
    Lange RF; Shulman NR; Tomasulo PA; Coleman CN
    Trans Assoc Am Physicians; 1973; 86():131-42. PubMed ID: 4363382
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].
    Scholz VC; Hoder A; Losert W
    Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels.
    Adams GA; Feuerstein IA
    Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals.
    Utsunomiya T; Krausz MM; Shepro D; Hechtman HB
    Am J Physiol; 1981 Nov; 241(5):H766-71. PubMed ID: 7030086
    [No Abstract]   [Full Text] [Related]  

  • 29. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin).
    Feinstein MB; Egan JJ; Sha'afi RI; White J
    Biochem Biophys Res Commun; 1983 Jun; 113(2):598-604. PubMed ID: 6307295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotides in platelet function.
    Haslam RJ; Davidson MM; Fox JE; Lynham JA
    Thromb Haemost; 1978 Oct; 40(2):232-40. PubMed ID: 216130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hypercholesterolaemia on the lipid composition and ability of human platelets to accumulate cyclic AMP.
    Jakubowski JA; Ardlie NG; Nestel PJ
    Prostaglandins Med; 1980 Dec; 5(6):457-67. PubMed ID: 6258183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prostaglandins, blood platelets, and thrombosis].
    Bousser MG
    Ann Med Interne (Paris); 1973 Apr; 124(4):351-4. PubMed ID: 4352683
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
    Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
    Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
    [No Abstract]   [Full Text] [Related]  

  • 35. Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins.
    Sinzinger H; O'Grady J; Fitscha P; Kaliman J
    N Engl J Med; 1984 Oct; 311(16):1052. PubMed ID: 6384781
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostaglandin E1 and platelets.
    Bousser MG
    Biomedicine; 1973 Mar; 18(2):95-102. PubMed ID: 4354464
    [No Abstract]   [Full Text] [Related]  

  • 39. [Platelet suppressive drugs (author's transl)].
    Shio H; Kameyama M
    No Shinkei Geka; 1981 Feb; 9(2):113-22. PubMed ID: 6264335
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
    Gabrielian ES; Akopov SE; Badzhinian SA
    Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.